US Patent Issued to Gencellmed on March 11 for "Recombinant herpes simplex virus having modified glycoprotein gH for retargeting and use thereof" (South Korean Inventors)

ALEXANDRIA, Va., March 12 -- United States Patent no. 12,246,048, issued on March 11, was assigned to Gencellmed Inc. (Seoul, South Korea).

"Recombinant herpes simplex virus having modified glycoprotein gH for retargeting and use thereof" was invented by Heechung Kwon (Gyeonggi-do, South Korea) and Hyunjung Baek (Gyeonggi-do, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "Proposed are a recombinant herpes simplex virus having a modified glycoprotein gH for retargeting and the use thereof. Particularly, the recombinant herpes simplex virus is capable of infecting a target cell having a target molecule to which a cell-targeting domain specifically recognizes and binds due to the presence of the cel...